• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

10
3
2
2
1

COUNTRY

2
1
1

CATEGORIES

  • 29
  • 10
  • 5
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

24
28
36
48

PUBLISHED

3
4
10
48

PRODUCT TYPE

28
10
9
1

Search "Acne Vulgaris" returned 48 results.

PRODUCT TITLE

Acne Vulgaris Global Clinical Trials Review, H2, 2013

Acne Vulgaris Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario....

September 2013
FROM

Acne Vulgaris Global Clinical Trials Review, H2, 2012

Acne Vulgaris Global Clinical Trials Review, H2, 2012 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2012" provides data on the Acne Vulgaris clinical trial scenario....

September 2012
FROM
Acne Vulgaris - Pipeline Review, H1 2013 Acne Vulgaris - Pipeline Review, H1 2013 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H1 2013

Acne Vulgaris – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM

Acne Vulgaris - Pipeline Review, H2 2013

Acne Vulgaris - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers Summary GBI Research’s report ‘Clinical Trial Recruitment in Dermatology...

October 2011
FROM
Acne Vulgaris - Pipeline Review, H2 2012 Acne Vulgaris - Pipeline Review, H2 2012 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H2 2012

Acne Vulgaris – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

August 2012
FROM

Acne Vulgaris Global Clinical Trials Review, H2, 2011

Acne Vulgaris Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2011" provides data on the Acne Vulgaris clinical...

November 2011
FROM

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

GBI Research, the leading business intelligence provider, has released its latest research ‘Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success...

January 2012
FROM
Acne Vulgaris - Pipeline Review, H1 2012 Acne Vulgaris - Pipeline Review, H1 2012 - Product Thumbnail Image

Acne Vulgaris - Pipeline Review, H1 2012

Acne Vulgaris – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

February 2012
FROM

Acne Vulgaris Global Clinical Trials Review, Q2, 2011

Acne Vulgaris Global Clinical Trials Review, Q2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, Q2, 2011" provides data on the Acne Vulgaris clinical...

June 2011
FROM

Acne Vulgaris-Pipeline Insights, 2014

This “ Acne Vulgaris-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

September 2014
FROM

Acne Vulgaris - Pipeline Review, Q1 2011

Acne Vulgaris - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, Q1 2011', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

February 2011
FROM

Acne Vulgaris - Pipeline Review, H2 2011

Acne Vulgaris - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2011', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

September 2011
FROM

Acne Vulgaris - Pipeline Review, Q4 2010

Acne Vulgaris - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Acne Vulgaris Pipeline Review, Q4 2010”, provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

December 2010
FROM

Acne Vulgaris Global Clinical Trials Review, Q4, 2010

Acne Vulgaris Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Acne Vulgari Global Clinical Trials Review, Q4, 2010" provides data on the Acne Vulgari clinical trial scenario....

December 2010
FROM

Acne Vulgaris - Pipeline Review, H1 2014

Acne Vulgaris - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H1 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report...

March 2014
FROM

OpportunityAnalyzer: Acne Vulgaris - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Acne Vulgaris - Opportunity Analysis and Forecasts to 2018 Summary Despite its considerable patient population, the acne market has been overlooked and remained stagnant for the...

June 2014
FROM

EpiCast Report: Acne - Epidemiology Forecast to 2022

EpiCast Report: Acne - Epidemiology Forecast to 2022 Summary Acne vulgaris (acne) is an inflammatory skin disease that affects nearly all adolescents and adults at some point in their lives. The clinical...

August 2013
FROM

Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment

GBI Research, the leading business intelligence provider, has released its latest research, ""Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New...

October 2012
FROM
Emerging Ingredients in Food and Drinks: Growth Opportunities in Flavors and Formulation by Product Category Emerging Ingredients in Food and Drinks: Growth Opportunities in Flavors and Formulation by Product Category - Product Thumbnail Image

Emerging Ingredients in Food and Drinks: Growth Opportunities in Flavors and Formulation by Product Category

Especially in the major market countries, more consumers are looking to buy food and drinks products comprised of ingredients that they perceive to be healthy For many consumers, food and drinks products...

August 2010
FROM
Loading Indicator